QGEN logo

Qiagen NV (QGEN)

Profile

Full Name

Qiagen N.V.

Ticker Symbol

QGEN

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

Netherlands

IPO

June 28, 1996

Indexes

Not included

Website

http://www.qiagen.com

Employees

5067

Key Details

Price

$42.32(+0.81%)

Market cap

$9.15B(Mid cap)

Last Dividend

$1.30

TTM Dividend yield

3.06%

Annual revenue

$1.98B(+0.66% YoY)

Annual EPS

$0.38(-75.00% YoY)

PE ratio

113.16

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$42.32
QGEN price is $42.32

30-Day Relative Volume

0.91
QGEN 30-day relative volume is 0.91

Price Performance

Price Most recent change

+0.81%
QGEN price was up +0.81% on Apr 14, 2025

Price YTD change

-4.96%
QGEN price is down -4.96% since January 1st

Price 1-year change

+5.33%
QGEN price is up +5.33% year-on-year

Price 3-year change

-9.78%
QGEN price is down -9.78% over the past 3 years

Price Range

Price All-time high

$60.81
QGEN price is currently -30.41% below its historical high of $60.81

Price 3-year low

$34.74
QGEN price is currently +21.82% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.15B
QGEN market capitalization is $9.15 billion

Market cap 3-year change

-9.1%
QGEN market capitalization is down -9.1% over the past 3 years

Market cap All-time high

$12.25B
QGEN market capitalization is currently -25.36% below its historical high of $12.25 billion

Market cap sector rank

92.11%
QGEN market capitalization is higher than 92.11% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.2%
QGEN shares outstanding is up +0.2% year-on-year

Shares Outstanding 3-Year Change

+0.75%
QGEN shares outstanding is up +0.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.56
QGEN beta is 0.56

200-day SMA

$43.05
QGEN price is currently -1.70% below its 200-day simple moving average

50-day SMA

$39.95
QGEN price is currently +5.94% above its 50-day simple moving average

RSI

59.23
QGEN 14-day relative strength index is 59.23

Volume

0.91
QGEN 30-day relative volume is 0.91

ATR

$1.35
QGEN average true range is $1.35

10-day Historical Volatility

65.23%
QGEN 10-day historical volatility is 65.23%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.30
QGEN last dividend was $1.30 per share, with an ex-dividend date of January 29, 2025

Next Dividend

-
QGEN next dividend has not yet been announced

Dividend per share

Dividend per share

$1.32
QGEN annual dividend per share is $1.32

Dividend per share Sector Rank

54.65%
QGEN annual dividend per share is higher than 54.65% of companies in Healthcare sector

Dividend per share 1-Year Change

-
QGEN annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
QGEN annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

3.11%
QGEN annual dividend yield is 3.11%

Dividend yield Sector Rank

63.53%
QGEN annual dividend yield is higher than 63.53% of companies in Healthcare sector

Other

Payout ratio

-
QGEN annual payout ratio value is unknown

Dividends paid

-
QGEN annual dividends paid value is unknown

Free cash flow

$502.31M
QGEN annual free cash flow is $502.31 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.98B
QGEN annual revenue is $1.98 billion

Revenue Analysts estimate

$2.04B
QGEN annual revenue is currently -2.94% lower than the consensus analysts' forecast

Revenue 1-year change

+0.66%
QGEN annual revenue is up +0.66% year-on-year

Revenue Sector rank

84.66%
QGEN annual revenue is higher than 84.66% of companies in Healthcare sector

EPS

EPS

$0.38
QGEN annual earnings per share is $0.38

EPS Analysts estimate

$2.30
QGEN annual earnings per share is currently -83.44% lower than the consensus analysts' forecast

EPS 1-year change

-75%
QGEN annual earnings per share is down -75% year-on-year

EPS Sector rank

86.52%
QGEN annual earnings per share is higher than 86.52% of companies in Healthcare sector

Profit

Gross profit

$967.35M
QGEN annual gross profit is $967.35 million

Gross margin

48.90%
QGEN annual gross profit margin is 48.90%

Operating profit

$199.90M
QGEN annual operating income is $199.90 million

Operating margin

10.11%
QGEN annual operating profit margin is 10.11%

Net income

$83.59M
QGEN annual net profit is $83.59 million

Net margin

4.23%
QGEN annual net profit margin is 4.23%

Expenses

Total expenses

$1.78B
QGEN annual total expenses is $1.78 billion

Operating expenses

$767.45M
QGEN annual total operating expenses is $767.45 million

Cost of goods sold

$1.01B
QGEN annual cost of goods sold is $1.01 billion

Selling, general & administrative expenses

$564.36M
QGEN annual SGA is $564.36 million

Depreciation and amortization

$203.27M
QGEN annual depreciation & amortization is $203.27 million

Interest expense

$43.84M
QGEN annual interest expense is $43.84 million

Income tax

$37.56M
QGEN annual income tax is $37.56 million

EBIT & EBITDA

EBIT

$164.99M
QGEN annual earnings before interest & taxes is $164.99 million

EBITDA

$368.26M
QGEN annual EBITDA is $368.26 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.69B
QGEN annual total assets is $5.69 billion

Non current assets

$3.73B
QGEN annual long term assets is $3.73 billion

Current assets

$1.96B
QGEN annual total current assets is $1.96 billion

Cash and cash equivalents

$663.55M
QGEN annual cash & cash equivalents is $663.55 million

Accounts receivable

$349.28M
QGEN annual accounts receivable is $349.28 million

Inventory

$279.26M
QGEN annual inventory is $279.26 million

Liabilities

Total liabilities

$2.12B
QGEN annual total liabilities is $2.12 billion

Long term liabilities

$1.58B
QGEN annual total long term liabilities is $1.58 billion

Current liabilities

$543.63M
QGEN annual total current liabilities is $543.63 million

Accounts payable

$83.27M
QGEN annual accounts payable is $83.27 million

Debt

Total debt

$1.39B
QGEN annual total debt is $1.39 billion

Total debt 1-year change

-9.17%
QGEN annual total debt is down -9.17% year-on-year

Long term debt

$1.34B
QGEN annual long term debt is $1.34 billion

Short term debt

$53.48M
QGEN annual short term debt is $53.48 million

Equity & Capital

Shareholders equity

$3.57B
QGEN annual stockholders equity is $3.57 billion

Book value

$3.57B
QGEN annual book value is $3.57 billion

Retained earnings

$2.45B
QGEN annual retained earnings is $2.45 billion

Working capital

$1.42B
QGEN annual working capital is $1.42 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$673.55M
QGEN annual cash flow from operations is $673.55 million

Cash from operations 1-year change

+46.6%
QGEN annual cash flow from operations is up +46.6% year-on-year

Cash from investing

-$249.23M
QGEN annual cash flow from investing activities is -$249.23 million

Cash from investing 1-year change

-184.33%
QGEN annual cash flow from investing activities is down -184.33% year-on-year

Cash from financing

-$422.90M
QGEN annual cash flow from financing activities is -$422.90 million

Cash from financing 1-year change

+2.52%
QGEN annual cash flow from financing activities is up +2.52% year-on-year

CAPEX

CAPEX

$171.24M
QGEN annual capital expenditures is $171.24 million

CAPEX 1-year change

+5.18%
QGEN annual capital expenditures is up +5.18% year-on-year

Free Cash Flow

Free cash flow

$502.31M
QGEN annual free cash flow is $502.31 million

Free cash flow 1-year change

+69.33%
QGEN annual free cash flow is up +69.33% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

48.90%
QGEN annual gross profit margin is 48.90%

Operating margin

10.11%
QGEN annual operating profit margin is 10.11%

Net margin

4.23%
QGEN annual net profit margin is 4.23%

ROA & ROE

ROA

1.42%
QGEN annual return on assets is 1.42%

ROE

2.27%
QGEN annual return on equity is 2.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

113.16
QGEN price to earnings ratio is 113.16

PE ratio Sector rank

92.16%
QGEN price to earnings ratio is higher than 92.16% of companies in Healthcare sector

PB Ratio

PB ratio

2.56
QGEN price to book ratio is 2.56

PB ratio Sector rank

69.38%
QGEN price to book ratio is higher than 69.38% of companies in Healthcare sector

PS Ratio

PS ratio

4.62
QGEN price to sales ratio is 4.62

PS ratio Sector rank

65%
QGEN price to sales ratio is higher than 65% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.90B
QGEN enterprise value is $9.90 billion

Enterprise value Sector rank

92.07%
QGEN enterprise value is higher than 92.07% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

26.88
QGEN EV/EBITDA is 26.88

EV/EBITDA Sector rank

93.91%
QGEN EV/EBITDA is higher than 93.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.61
QGEN annual current ratio is 3.61

Quick ratio

3.09
QGEN annual quick ratio is 3.09

Leverage

Debt to equity

0.39
QGEN annual debt to equity ratio is 0.39

Interest coverage ratio

3.76
QGEN annual interest coverage ratio is 3.76

Risk & Stability

Piotroski F-Score

7
QGEN piotroski f-score is 7

Altman Z-Score

3.93
QGEN altman z-score is 3.93

Analyst ratings

Recent major analysts updates

Apr 4, 25 Redburn Atlantic
Neutral
Feb 19, 25 Baird
Neutral
Feb 7, 25 UBS
Neutral
Jan 6, 25 Morgan Stanley
Equal-Weight
Dec 10, 24 Jefferies
Buy
Oct 17, 23 JP Morgan
Overweight
Sep 26, 23 Citigroup
Buy
Sep 12, 23 Baird
Outperform
Aug 9, 23 UBS
Neutral
Feb 9, 23 UBS
Neutral

Institutional Ownership

Similar stocks

VTRS logo
Viatris (VTRS)
MEDP logo
Medpace Holdings (MEDP)
ASND logo
Ascendis Pharma A/S (ASND)
WBA logo
Walgreens Boots Alliance (WBA)
NBIX logo
Neurocrine Biosciences (NBIX)
CHE logo
Chemed (CHE)
ATR logo
AptarGroup (ATR)
DOCS logo
Doximity (DOCS)
TECH logo
Bio-Techne (TECH)
  • What is the ticker symbol for Qiagen NV?
  • Does Qiagen NV pay dividends?
  • What sector is Qiagen NV in?
  • What industry is Qiagen NV in?
  • What country is Qiagen NV based in?
  • When did Qiagen NV go public?
  • Is Qiagen NV in the S&P 500?
  • Is Qiagen NV in the NASDAQ 100?
  • Is Qiagen NV in the Dow Jones?
  • When was Qiagen NV's last earnings report?
  • When does Qiagen NV report earnings?
  • Should I buy Qiagen NV stock now?

What is the ticker symbol for Qiagen NV?

The ticker symbol for Qiagen NV is NYSE:QGEN

Does Qiagen NV pay dividends?

Yes, Qiagen NV pays dividends. The last payment was $1.30, with an ex-dividend date on January 29, 2025

What sector is Qiagen NV in?

Qiagen NV is in the Healthcare sector

What industry is Qiagen NV in?

Qiagen NV is in the Diagnostics & Research industry

What country is Qiagen NV based in?

Qiagen NV is headquartered in Netherlands

When did Qiagen NV go public?

Qiagen NV's initial public offering (IPO) was on June 28, 1996

Is Qiagen NV in the S&P 500?

No, Qiagen NV is not included in the S&P 500 index

Is Qiagen NV in the NASDAQ 100?

No, Qiagen NV is not included in the NASDAQ 100 index

Is Qiagen NV in the Dow Jones?

No, Qiagen NV is not included in the Dow Jones index

When was Qiagen NV's last earnings report?

Qiagen NV's most recent earnings report was on Feb 5, 2025

When does Qiagen NV report earnings?

The next expected earnings date for Qiagen NV is May 7, 2025

Should I buy Qiagen NV stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page